Publications

Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer's Disease, Mroczek M , Clark C, Dayon L, Bowman G, Popp J; PMID: 35326481 DOI: 10.3390/cells11061030

Clark C, Dayon L, Masoodi M, Bowman GL, Popp J. An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease. Alzheimers Res Ther. 2021 Apr 1;13(1):71. DOI: 10.1186/s13195-021-00814-7

Clark C, Lewczuk P, Kornhuber J, Richiardi J, Maréchal B, Karikari TK, Blennow K, Zetterberg H, Popp J. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression. Alzheimers Res Ther. 2021 Mar 25;13(1):65 DOI: 10.1186/s13195-021-00805-8

Zullo L, Clark C, Gholam M, Castelao E, von Gunten A, Preisig M, Popp J. Factors associated with subjective cognitive decline in dementia-free older adults-A population-based study. Int J Geriatr Psychiatry. 2021 Feb 8. DOI: 10.1002/gps.5509

Jahn T, Clark C, Kerksiek A, Lewczuk P, Lütjohann D, Popp J. Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer's cerebral pathology and clinical disease progression. J Steroid Biochem Mol Biol. 2021 Jan;205:105785. DOI: 10.1016/j.jsbmb.2020.105785

van der Velpen V, Teav T, Gallart-Ayala H, Mehl F, Konz I, Clark C, Oikonomidi A, Peyratout G, Henry H, Mauro Delorenzi M, Ivanisevic J*, Popp J*. Systemic and central nervous system metabolic alterations in Alzheimer’s disease Alzheimers Res Ther. 2019 Nov 28;11(1):93 *Popp and Ivanisevic: equal contribution DOI: 10.1186/s13195-019-0551-7

Dayon L, Wojcik J, Galindo AL, Corthésy J, Cominetti O, Oikonomidi A, Henry H, Migliavacca E, Bowman GM, Popp J. Alzheimer disease pathology and the cerebrospinal fluid proteome. Alzheimers Res Ther. 2018. DOI: 10.1186/s13195-018-0397-4

Bowman GM, Dayon L, Kirkland R, Wojcik J, Peyratout G, Severin I, Henry H, Oikonomidi A, Migliavacca E, Bacher M, Popp J. Blood-brain barrier breakdown, neuroinflammation and cognitive decline in older adults. Alzheimer's & Dementia. 2018 Dec;14(12):1640-1650. DOI: 10.1016/j.jalz.2018.06.2857

Haba-Rubio J, Marti-Soler H, Tobback N, Andries D, Marques-Vidal P, Waeber G, Vollenweider P, von Gunten A, Preisig M, Castelao E, Tafti M, Heinzer R, Popp J. Sleep characteristics and cognitive impairment in the general population: The HypnoLaus study. Neurology 2017 Jan 31;88(5):463-469 DOI: 10.1212/WNL.0000000000003557

Popp J, Oikonomidi A, Tautvydaitė D, Dayon L, Bacher M, Migliavacca E, Henry H, Severin I, Kirkland R, Wojcik J, Bowman GM. Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults. Brain, Behavior, and Immunity. 2017 May;62:203-21. DOI: DOI: 10.1016/j.bbi.2017.01.020

Dayon L, Oikonomidi A, Migliavacca E, Henry H, Severin I, Kirkland R, Wojcik J, Bowman GM, Popp J. One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: Homocysteine and beyond. Alzheimers Res Ther. 2017. DOI: 10.1186/s13195-017-0270-x